Year |
Citation |
Score |
2023 |
Mitra Ghosh T, Mazumder S, Davis J, Yadav J, Akinpelu A, Alnaim A, Kumar H, Waliagha R, Church Bird AE, Rais-Bahrami S, Bird RC, Mistriotis P, Mishra A, Yates CC, Mitra AK, et al. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. Cancer Research Communications. 3: 1286-1311. PMID 37476073 DOI: 10.1158/2767-9764.CRC-22-0427 |
0.774 |
|
2023 |
Davis JT, Ghosh TM, Mazumder S, Mitra A, Bird RC, Arnold RD. Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences. 24. PMID 37239838 DOI: 10.3390/ijms24108490 |
0.749 |
|
2022 |
Habbit NL, Anbiah B, Anderson L, Suresh J, Hassani I, Eggert M, Brannen A, Davis J, Tian Y, Prabhakarpandian B, Panizzi P, Arnold RD, Lipke EA. Tunable three-dimensional engineered prostate cancer tissues for in vitro recapitulation of heterogeneous in vivo prostate tumor stiffness. Acta Biomaterialia. PMID 35551999 DOI: 10.1016/j.actbio.2022.05.011 |
0.783 |
|
2021 |
Mitra Ghosh T, Kansom T, Mazumder S, Davis J, Alnaim AS, Jasper SL, Zhang C, Bird A, Opanasopit P, Mitra AK, Arnold RD. . The Journal of Pharmacology and Experimental Therapeutics. PMID 34949650 DOI: 10.1124/jpet.121.000898 |
0.731 |
|
2021 |
Mitra Ghosh T, White J, Davis J, Mazumder S, Kansom T, Skarupa E, Barnett GS, Piazza GA, Bird RC, Mitra AK, Yates C, Cummings BS, Arnold RD. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Frontiers in Pharmacology. 12: 736951. PMID 34938177 DOI: 10.3389/fphar.2021.736951 |
0.655 |
|
2020 |
Alnaim AS, Arnold R, Eggert M, Nie B, Jasper S, Davis J, Panizzi P, Cummings B, Quach N. Role of PLA2R1 and sPLA2 on Drug Release and Uptake of Liposome Nanoparticles in Prostate Cancer The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.03071 |
0.735 |
|
2019 |
Ghosh TM, Mitra AK, Davis J, Cummings B, Yates C, Arnold R. Abstract LB-267: Transcriptomic and epigenomic analysis of metastatic castration-resistant prostate cancer and a pan-cancer analysis of its genetic signatures Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-Lb-267 |
0.79 |
|
2019 |
Davis J, Ghosh TM, Jasper L, Eggert M, Warner J, Cummings B, Arnold R. Abstract 32: Development of a three-dimensional spheroid model system to more accurately evaluate schedule dependent mechanistic differences between metronomic and conventional dosing of topotecan Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-32 |
0.651 |
|
2019 |
Alnaim AS, Eggert MW, Nie B, Quanch ND, Jasper SL, Davis J, Barnett GS, Cummings BS, Panizzi PR, Arnold RD. Abstract 2985: Identifying uptake and biodistribution of liposome nanoparticles associated with secretes phospholipase A2proteins and PLA2receptors within a prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2985 |
0.789 |
|
2019 |
Ghosh TM, Davis J, Barnett GS, Skarupa E, Warner JD, Cummings BS, Arnold RD. Abstract 2944: Identification of key transcriptomic and epigenomic factors influencing conventional and metronomic dosing in aggressive and non-aggressive prostate cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2944 |
0.786 |
|
2016 |
Kaye S, Johnson S, Arnold RD, Nie B, Davis JT, Gulland F, Abou-Madi N, Fletcher DJ. PHARMACOKINETIC STUDY OF ORAL ε-AMINOCAPROIC ACID IN THE NORTHERN ELEPHANT SEAL (MIROUNGA ANGUSTIROSTRIS). Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians. 47: 438-446. PMID 27468014 DOI: 10.1638/2015-0138.1 |
0.729 |
|
Show low-probability matches. |